Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Cesca Therapeutics Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Cesca Therapeutics Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Cesca Therapeutics Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Cesca Therapeutics Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
| Cesca Therapeutics Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| Cesca Therapeutics Inc., Medical Equipment, Deal Details | 12 | 29 |
| Partnerships | 12 | 1 |
| ThermoGenesis Enters Into Licensing Agreement With BioParadox | 12 | 1 |
| Asahi Kasei Kuraray Medical And ThermoGenesis Amends Licensing Agreement | 13 | 1 |
| Cesca Therapeutics Amends Licensing Agreement with CBR Systems | 14 | 1 |
| Texas Stem Cell Enters into Agreement with Cesca Therapeutics | 15 | 1 |
| Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec | 16 | 1 |
| ThermoGenesis Enters Into Co-Marketing Agreement With Golden Meditech Holdings | 17 | 1 |
| Thermogenesis Enters Into Distribution Agreement With Arthrex For Res-Q System | 18 | 1 |
| ThermoGenesis Enters Into Distribution Agreement With Nanshan Memorial Medical | 19 | 1 |
| ThermoGenesis Signs Distribution Agreement With GE Healthcare | 20 | 1 |
| ThermoGenesis Enters Into Distribution Agreement With Fenwal | 21 | 1 |
| Merger | 22 | 1 |
| TotipotentRx Completes Merger With ThermoGenesis | 22 | 2 |
| Equity Offering | 24 | 1 |
| Cesca Therapeutics Prices Private Placement of Shares for USD2.5 Million | 24 | 2 |
| Cesca Therapeutics to Raise USD2.5 Million in Private Placement of Shares | 26 | 2 |
| Cesca Therapeutics Raises USD11.3 Million in Public Offering of Units | 28 | 2 |
| ThermoGenesis Completes Private Placement Of Common Stock And Warrants For US$6.7 Million | 30 | 2 |
| ThermoGenesis Completes Public Offering Of Units For US$4.5 Million | 32 | 2 |
| Debt Offering | 34 | 1 |
| Cesca Therapeutics to Raise USD12.5 Million in Private Placement of 22% Debentures Due 2019 | 34 | 1 |
| Cesca Therapeutics Raises USD5.5 Million in First Tranche of Private Placement of Debentures Due 2045 | 35 | 1 |
| Asset Transactions | 36 | 1 |
| Helmer Acquires Thermoline Plasma Freezer And Thawer Product Line Of Thermogenesis | 36 | 2 |
| Asahi Kasei Completes Acquisition Of CryoSeal FS System From ThermoGenesis For US$2 Million | 38 | 2 |
| ThermoGenesis To Sell CryoSeal Fibrin Sealant System Wound Care Product Line | 40 | 1 |
| Cesca Therapeutics Inc. - Key Competitors | 41 | 1 |
| Key Employees | 42 | 1 |
| Locations And Subsidiaries | 43 | 1 |
| Head Office | 43 | 1 |
| Other Locations &Subsidiaries | 43 | 1 |
| Recent Developments | 44 | 1 |
| Financial Announcements | 44 | 1 |
| Sep 20, 2016: Cesca Therapeutics Reports Fourth Quarter and Fiscal 2016 Year End Results | 44 | 2 |
| May 12, 2016: Cesca Therapeutics Reports Third Quarter Fiscal 2016 Results and Provides Business Update | 46 | 1 |
| Feb 16, 2016: Cesca Therapeutics Reports Second Quarter Fiscal 2016 Results and Provides a Status Update to Investors | 47 | 1 |
| Nov 16, 2015: Cesca Therapeutics Reports First Quarter Fiscal Year 2016 Financial Results | 48 | 2 |
| Sep 17, 2015: Cesca Therapeutics Reports Fiscal Year 2015 Results | 50 | 2 |
| Jun 23, 2015: Cesca Therapeutics Reports Third Quarter Fiscal 2015 Results | 52 | 1 |
| Feb 12, 2015: Cesca Therapeutics Reports Second Quarter Fiscal 2015 Results | 53 | 1 |
| Corporate Communications | 54 | 1 |
| Jun 20, 2016: Cesca Therapeutics Appoints Mark Bagnall to Its Board of Directors | 54 | 1 |
| Mar 23, 2016: Cesca Therapeutics Appoints Vascular Surgery Expert Lars Norgren, M.D., Ph.D., to its Clinical Advisory Board | 55 | 1 |
| Mar 10, 2016: Cesca Therapeutics Appoints Dr. Xiaochun Xu, Chairman and CEO of Boyalife Group, to Board of Directors | 56 | 1 |
| Oct 26, 2015: Michael Bruch Appointed Chief Financial Officer of Cesca Therapeutics | 57 | 1 |
| Sep 28, 2015: Ken Harris to Step Down as President of Cesca Therapeutics | 58 | 1 |
| Sep 15, 2015: Cesca Therapeutics Announces Restructuring Initiative | 59 | 1 |
| Jun 12, 2015: Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer | 60 | 1 |
| May 04, 2015: Cesca Therapeutics Announces Changes in Management | 61 | 1 |
| Product News | 62 | 1 |
| Dec 02, 2015: Cesca Receives Approval for Medicare Coverage | 62 | 1 |
| Oct 23, 2015: Cesca Therapeutics to Present Progress on Its CellWerks Product Pipeline at the AABB Conference in Anaheim, California, October 24-27 | 63 | 1 |
| May 13, 2015: Cesca Therapeutics Submits U.S. Pivotal IDE Amendment Application for Late Stage Critical Limb Ischemia (CLI) | 64 | 1 |
| Apr 10, 2015: Cesca Therapeutics Management Provides Update on Clinical Trials for Acute Myocardial Infarction | 65 | 1 |
| Apr 10, 2015: Cesca Therapeutics Management Provides Update on Clinical Trials for Critical Limb Ischemia | 66 | 1 |
| Feb 11, 2015: Cesca Therapeutics Announces Approval of its MarrowXpress System in India | 67 | 1 |
| Product Approvals | 68 | 1 |
| Feb 11, 2015: Cesca Therapeutics Announces Approval of its MarrowXpress System in India | 68 | 1 |
| Clinical Trials | 69 | 1 |
| Apr 10, 2015: Cesca Therapeutics Management Provides Update on Clinical Trials for Acute Myocardial Infarction | 69 | 1 |
| Apr 10, 2015: Cesca Therapeutics Management Provides Update on Clinical Trials for Critical Limb Ischemia | 70 | 1 |
| Other Significant Developments | 71 | 1 |
| Oct 19, 2015: Cesca Therapeutics Clinical Laboratory Successfully Facilitates Haploidentical Bone Marrow Transplant Procedure on Unique Pediatric Patient in Need | 71 | 1 |
| Appendix | 72 | 1 |
| Methodology | 72 | 1 |
| About GlobalData | 72 | 1 |
| Contact Us | 72 | 1 |
| Disclaimer | 72 | 1 |